methoxy[hexa(ethylene glycol)] methacrylate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methoxy[hexa(ethylene glycol)] methacrylate
• 英文别名: methoxy hexa(ethylene glycol) methacrylate；methoxyhexa(ethylene glycol) methacrylate；methoxy hexaethylene glycol methacrylate；m-PEG6-2-methylacrylate；2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate
• 化学式: C₁₇H₃₂O₈
• 分子量: 364.436
• InChiKey: FVSGBTSAXJGUNZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  25
• 可旋转键数：
  20
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  81.7
• 氢给体数：
  0
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  methoxy[hexa(ethylene glycol)] methacrylate 生成 polymer, M_n 2980 Da, M_w/M_n 1.26; monomer(s): methoxy hexa(ethylene glycol) methacrylate
  参考文献：
  名称：

  摘要：

  DOI：

文献信息

• BINDER COMPOSITION FOR NON-AQUEOUS SECONDARY BATTERY ELECTRODE
  申请人：Kinoshita Sachiko

  公开号：US20120095131A1

  公开（公告）日：2012-04-19

  Disclosed is a binder composition for a non-aqueous secondary battery electrode, which enables the production of a non-aqueous secondary battery that has excellent adhesion to a current collector or an electrode and can retain a high electric discharge capacity even when charge and discharge are repeated or under a high-temperature environment produced as a result of the generation of heat. Specifically disclosed is a binder composition for a non-aqueous secondary battery electrode, which comprises functional group-containing crosslinked resin microparticles produced by polymerizing the following components (A) to (C): (A) at least one monomer selected from the group consisting of (a) a monomer having one ethylenically unsaturated group per molecule and also having a monofunctional or polyfunctional epoxy group, (b) a monomer having one ethylenically unsaturated group per molecule and also having a monofunctional or polyfunctional amide group, and (c) a monomer having one ethylenically unsaturated group per molecule and also having a monofunctional or polyfunctional hydroxy group; (B) at least one monomer selected from the group consisting of (d) a monomer having one ethylenically unsaturated group per molecule and also having an alkoxysilyl group and (e) a monomer having at least two ethylenically unsaturated groups per molecule; and (C) (k) a monomer which has an ethylenically unsaturated group and is different from the monomers (a) to (e).

  本发明公开了一种用于非水性二次电池电极的粘合剂组合物，该组合物能够生产出具有优异附着力的非水性二次电池，该电池能够在充放电重复或因产生热而产生高温环境下保持高电放电容量。具体而言，本发明公开了一种用于非水性二次电池电极的粘合剂组合物，该组合物包括通过聚合以下组分（A）至（C）制备的含有功能性基团的交联树脂微粒：（A）选自以下组中的至少一种单体，所述组包括（a）每个分子具有一个乙烯基不饱和基团并且还具有单官能或多官能环氧基团的单体，（b）每个分子具有一个乙烯基不饱和基团并且还具有单官能或多官能酰胺基团的单体，以及（c）每个分子具有一个乙烯基不饱和基团并且还具有单官能或多官能羟基团的单体；（B）选自以下组中的至少一种单体，所述组包括（d）每个分子具有一个乙烯基不饱和基团并且还具有烷氧基基团的单体和（e）每个分子具有至少两个乙烯基不饱和基团的单体；以及（C）（k）一种具有乙烯基不饱和基团且与单体（a）至（e）不同的单体。
• ALKYNE-, AZIDE- AND TRIAZOLE-CONTAINING FLAVONOIDS AS MODULATORS FOR MULTIDRUG RESISTANCE IN CANCERS
  申请人：The Hong Kong Polytechnic University

  公开号：US20150011513A1

  公开（公告）日：2015-01-08

  A triazole bridged flavonoid dimer compound library was efficiently constructed via the cycloaddition reaction of a series of flavonoid-containing azides (Az 1-15) and alkynes (Ac 1-17). These triazole bridged flavonoid dimers and their precursor alkyne- and azide-containing flavonoids were screened for their ability to modulate multidrug resistance (MDR) in P-gp-overexpressed cell line (LCC6MDR), MRP1-overexpressed cell line (2008/MRP1) and BCRP-overexpressed cell line (HEK293/R2 and MCF7-MX100). Generally, they displayed very promising MDR reversal activity against P-gp-, MRP1- and BCRP-mediated drug resistance. Moreover, they showed different levels of selectivity for various transporters. Overall, they can be divided into mono-selective, dual-selective and multi-selective modulators for the P-gp, MRP1 and BCRP transporters. The EC50 values for reversing paclitaxel resistance (141-340 nM) of LCC6MDR cells, DOX (78-590 nM) and vincristine (82-550 nM) resistance of 2008/MRP1 cells and topotecan resistance (0.9-135 nM) of HEK293/R2 and MCF7-MX100 cells were at nanomolar range. Importantly, a number of compounds displayed EC50 at or below 10 nM in BCRP-overexpressed cell lines, indicating that these bivalent triazoles more selectively inhibit BCRP transporter than the P-gp and MRP1 transporters. Most of the dimers are notably safe MDR chemosensitizers as indicated by their high therapeutic index values.

  通过一系列含有三唑桥联类黄酮二聚物的合成，使用环加成反应，利用一系列含有黄酮基团的叠氮化物（Az1-15）和炔烃（Ac1-17）构建了一个高效的化合物库。这些三唑桥联的类黄酮二聚体及其前体炔基和叠氮基类黄酮被筛选，以评估它们对过表达P-gp的细胞系（LCC6MDR）、MRP1过表达的细胞系（2008/MRP1）和BCRP过表达的细胞系（HEK293/R2和MCF7-MX100）调节多药耐药性（MDR）的能力。总体而言，它们展现了极具前景的P-gp、MRP1和BCRP介导的药物耐药性的MDR逆转活性。此外，它们显示出对各种转运体的不同程度的选择性。总体而言，它们可以分为单选择性、双选择性和多选择性的P-gp、MRP1和BCRP转运体调节剂。对于LCC6MDR细胞的紫杉醇耐药性（141-340 nM）、2008/MRP1细胞的DOX（78-590 nM）和长春新碱（82-550 nM）耐药性以及HEK293/R2和MCF7-MX100细胞的拓扑替康耐药性（0.9-135 nM），它们的EC50值处于纳摩尔范围。重要的是，许多化合物在BCRP过表达的细胞系中显示出EC50值在或低于10 nM，表明这些双价三唑更有选择性地抑制BCRP转运体而不是P-gp和MRP1转运体。大多数二聚体的治疗指数值非常高，表明它们是非常安全的MDR化疗敏感剂。
• FINE METAL PARTICLE DISPERSANT, FINE METAL PARTICLE DISPERSED LIQUID, AND CURED FILM
  申请人：Harima Chemicals, Inc.

  公开号：EP2962750A1

  公开（公告）日：2016-01-06

  A metal fine particle dispersant is obtained by reaction of a polymer (a) containing a first reactive functional group, an ionic group to be absorbed to metal fine particles, and a polyoxyalkylene side chain with a compound (b) containing a second reactive functional group to be bonded to the first reactive functional group and an active energy ray curable group to be cured by an active energy ray. A metal fine particle dispersion liquid containing the metal fine particle dispersant, metal fine particles, and a dispersion medium is prepared. The metal fine particle dispersion liquid is cured, thereby obtaining a cured film.

  将含有第一活性官能团、可被金属微粒吸收的离子基团和聚氧亚烷基侧链的聚合物 (a) 与含有可与第一活性官能团结合的第二活性官能团和可被活性能量射线固化的活性能量射线可固化基团的化合物 (b) 反应，可获得金属微粒分散剂。制备含有金属微粒分散剂、金属微粒和分散介质的金属微粒分散液。固化金属微粒分散液，从而获得固化薄膜。
• PHOTOCURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE
  申请人：ThreeBond Co., Ltd.

  公开号：EP3907246A1

  公开（公告）日：2021-11-10

  An object of the present invention is to provide a photocurable resin composition capable of obtaining a cured product having excellent quick curability by irradiation with a low integrated light intensity and flexibility. A photocurable resin composition containing the following components (A) to (E): component (A): a monofunctional urethane (meth)acrylate having a polyether skeleton; component (B): a monofunctional (meth)acrylic monomer having a polyether skeleton and having no urethane skeleton; component (C): a photoradical polymerization initiator; component (D): a polyfunctional (meth)acrylic monomer having 4 or more functionalities; and component (E): a polyester-based plasticizer having no (meth)acryloyl group.

  本发明的目的是提供一种光固化树脂组合物，该组合物能够通过低综合光强辐照获得 具有优异快速固化性和柔韧性的固化产品。 一种光固化树脂组合物含有以下组分（A）至（E）： 组分 (A)：具有聚醚骨架的单官能度聚氨酯（甲基）丙烯酸酯； 组分 (B)：具有聚醚骨架但没有氨基甲酸酯骨架的单官能度（甲基）丙烯酸酯单体； 组分 (C)：一种光绶聚合引发剂； 组分 (D)：具有 4 个或更多官能度的多官能度（甲基）丙烯酸单体；以及 组分（E）：不含（甲基）丙烯酰基的聚酯基增塑剂。
• (METH)ACRYLATE COPOLYMER, A METHOD FOR PRODUCING THE SAME AND A MEDICAL DEVICE
  申请人：Kawakatsu Yuta

  公开号：US20100069595A1

  公开（公告）日：2010-03-18

  [Object] An object of the present invention is to provide a surface-treating agent excellent in antithrombogenicity, and accordingly, excellent in biocompatibility, and having high hydrophilicity as compared with conventional medical materials. Further, an object of the present invention is to provide a production method excellent in performance of removing unreacted monomers and further improving a yield as compared with conventional production methods. [Constitution] The present invention relates to a water-insoluble copolymer comprising alkyl(meth)acrylate and methoxypolyethylene glycol(meth)acrylate. The present invention also relates to a method for producing a water-insoluble (meth)acrylate copolymer by copolymerizing alkyl(meth)acrylate and methoxypolyethylene glycol(meth)acrylate in a common polymerization solvent. Further, the present invention relates to a method for purifying (meth)acrylate copolymer by purifying (meth)acrylate copolymer by reprecipitation using a mixed solution of an alcohol having 1 to 10 carbon atoms and water.